Brannin McBee

CDO Brannin McBee sells 52,500 shares (52.5K) for $5,841,960.97 at CoreWeave under 10b5-1 plan

Brannin McBee, Chief Development Officer, executed 24 separate sales totaling 52,500 shares for $5,841,960.97 ($5.8M) on 2026-06-22 under a pre-arranged 10b5-1 trading plan adopted on 2026-03-05. This represents the non-derivative portion of his holdings; he retains 4,320,932 shares through two GRATs (Canis Major 2025 GRAT: 3,797,227 shares; Canis Minor 2025 GRAT: 523,705 shares). The blended average price across the 24 transactions was $111.28, while the current stock price is $100.88, representing a -46.0% decline from the 52-week high of $187.00. CoreWeave's fundamentals show Revenue of $2,078,000,000.00 (latest quarter) against Net income of $-740,000,000.00, with the company unprofitable over its most recent full fiscal year despite Annual revenue growth of +167.9%. McBee's same-ticker trading history at CRWV shows 5 prior sells on 2026-06-15 (outcomes not yet measurable). The scheduled nature of this sale under the 10b5-1 plan means it proceeded according to a predetermined arrangement rather than in response to current market or business conditions.

CoreWeave CDO Brannin McBee sold 28,000 shares on 2026-06-22 via 10b5-1 plan for $3,115,712.52

Brannin McBee, Chief Development Officer of CoreWeave, executed 24 separate sales totaling 28,000 shares for $3,115,712.52 on 2026-06-22 at an average price of $111.28 per share. This transaction was conducted under a pre-arranged 10b5-1 trading plan adopted on 2026-03-05, meaning the sale was scheduled rather than discretionary. While this particular tranche eliminated his non-derivative holdings, McBee retains 3,881,020 shares through derivative vehicles (Class B Common Stock held in two irrevocable trusts), preserving significant economic exposure to CoreWeave. The current stock price of $100.88 is -46.0% from the 52-week high of $187.00, and the company reported a net loss of $-740,000,000.00 on revenue of $2,078,000,000.00 in the latest quarter, illustrating the unprofitable operational context in which this scheduled disposition occurred.

CDO Brannin McBee sells 169,000 shares for $18.8M via 24 tranches at blended $111.28; stock at -46.0% from 52-week high under scheduled 10b5-1 plan

McBee executed 24 separate sales totaling 169,000 shares for $18,805,572.95 under a pre-arranged 10b5-1 trading plan adopted on 2026-03-05, meaning the transactions were scheduled rather than discretionary. The sales occurred at prices ranging from $107.05 to $119.00 on 2026-06-22, with a blended average of $111.28, while the current stock price is $100.88—representing a -46.0% decline from the 52-week high of $187.00. The non-derivative holdings after this transaction show 0 shares, though McBee retains Class B Common Stock positions including 6,618,894 shares direct and 2,005,300 shares by spouse, meaning the overall position remains material. Context matters: the company posted annual revenue growth of +167.9% on $2,078,000,000.00 in latest quarterly revenue but is deeply unprofitable with net income of $-740,000,000.00 for its most recent full fiscal year, presenting a high-growth but loss-making profile typical of infrastructure/AI companies.

Chief Development Officer Brannin McBee sold 52,500 shares for $5,633,030.41 via 10 scheduled transactions on 2026-06-15 under pre-arranged 10b5-1 plan

Brannin McBee sold 52,500 shares across 10 separate transactions totaling $5,633,030.41 at a blended average price of $107.30, with the current stock price at $115.21. This sale was executed under a pre-arranged 10b5-1 trading plan adopted on 2026-03-05, meaning the transactions were scheduled rather than discretionary. McBee retains substantial derivative holdings of 4,373,432 shares across two GRAT vehicles (Canis Major 2025 and Canis Minor 2025). Notably, McBee's prior sales at this ticker show consistently negative 30-day and 90-day returns (ranging from -3.0% to -6.5% over 30 days, and -8.4% to -11.7% over 90 days), suggesting these recent scheduled sales would have netted better prices if executed earlier. The company generated $2,078,000,000 in revenue but posted a net loss of $-740,000,000 in the latest quarter, though annual revenue growth reached +167.9%, creating a mixed fundamental picture amid a high-growth but unprofitable operating environment.

Brannin McBee (CDO) sold 197,500 shares for $21,190,931.21 on 2026-06-15 via pre-arranged 10b5-1 plan; retains substantial derivative holdings across multiple trusts.

Brannin McBee, Chief Development Officer, executed 25 separate sales totaling 197,500 shares for $21,190,931.21 at a blended average price of $107.30 on 2026-06-15, reducing his non-derivative holdings from 250,500 shares to 53,000 shares. This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2026-03-05, meaning the sales were scheduled rather than discretionary. Despite the significant reduction in direct common stock holdings, McBee retains 12,702,214 shares across derivative vehicles including Class B Common Stock holdings in his name, by spouse, and through two irrevocable trusts (Brannin J. McBee 2022 Irrevocable Trust and Canis Major 2024 Irrevocable Trust LLC). The stock price has risen 11.0% over the prior 30 days and 42.8% over the prior 90 days, trading at $115.21 versus a 52-week high of $187.00. However, the company reported a net loss of $-740,000,000.00 in the latest quarter against revenue of $2,078,000,000.00, indicating CoreWeave remains unprofitable despite strong 167.9% annual revenue growth. McBee's prior five sales at CRWV (all on 2026-04-27) showed 90-day returns ranging from -11.7% to -8.4%, establishing a pattern of post-sale price appreciation at this ticker.

CDO Brannin McBee sold 55,500 shares for $5,652,017.21 via 18 scheduled trades on 2026-06-08; stock down -16.6% in 30 days.

Brannin McBee, Chief Development Officer at CoreWeave, executed 18 separate sales totaling 55,500 shares for $5,652,017.21 on 2026-06-08 at a blended average price of $101.84 under a pre-arranged 10b5-1 trading plan adopted on 2026-03-05. The insider retains 4,746,932 shares through derivative holdings across three ownership vehicles. The stock has declined -16.6% over the 30-day period following the transaction date and trades at $95.61, approximately -48.9% from the 52-week high of $187.00. CoreWeave reported $2.1B in latest-quarter revenue with annual growth of +167.9%, but remains unprofitable with a net loss of -$740.0M over its most recent full fiscal year. The insider's cross-ticker track record shows 20 prior sells with an average 90-day return of -9.4%, while his five prior sales at CRWV on 2026-04-27 exhibited 30-day returns ranging from -3.0% to -6.5% and 90-day returns from -8.4% to -11.7%.

CDO Brannin McBee sold 194,500 shares (78.4% of pre-transaction holding) for $19.8M under 10b5-1 plan on 2026-06-08

Brannin McBee, Chief Development Officer, executed 24 separate sales totaling 194,500 shares for $19,807,534.25 on 2026-06-08 under a pre-arranged 10b5-1 trading plan adopted on 2026-03-05—a scheduled transaction, not a discretionary trade. The blended average sale price was $101.84, while the current price now stands at $95.61, representing a -48.9% decline from the 52-week high of $187.00. McBee's holdings after this filing total 53,500 non-derivative shares, down from 248,000 pre-transaction, but his derivative holdings across three ownership vehicles remain substantial at 12,578,214 shares total. His prior sales at this ticker on 2026-04-27 recorded 90-day returns of -11.7%, -11.6%, -9.4%, and -8.4%, reflecting the stock's volatile trading environment. CoreWeave remains unprofitable with net income of -$740,000,000 in its most recent full fiscal year, though revenue grew 167.9% year-over-year to $2,078,000,000.

CDO McBee Brannin sells entire converted stake: 287.5K shares in 24 transactions for $31.3M at blended $109.03

McBee Brannin, Chief Development Officer, executed 24 separate sales on 2026-04-27 totaling 287,500 shares for $31,346,733.16 ($31.3M) at prices ranging from $105.61 to $112.18, with a blended average of $109.03. Post-transaction holdings are 0 shares, representing a -100.0% reduction from the 287.5K shares held prior. The filing FLAG indicates this is a derivative-conversion transaction—the shares derive from converting derivative securities, and the insider's full position resides in Form 4 Table II (not yet populated in our database), so this sale should not be characterized as a complete liquidation of total position. The current stock price of $114.19 is +5.0% above the blended transaction price and -37.8% from the 52-week high of $183.58. Fundamentals show the company generated $1,364,676,000 in latest quarterly revenue with +167.9% annual growth, but posted a net loss of $-110,124,000 over the most recent full fiscal year, indicating unprofitable operations despite strong revenue expansion. No measurable 30-day or 90-day outcomes are yet available for same-ticker prior trades or this transaction itself.

CoreWeave CDO McBee Brannin sold 45,850 shares for $4,998,934.01 across 16 transactions at blended average price $109.03 on 2026-04-27.

McBee Brannin, Chief Development Officer, executed 16 separate sales totaling 45,850 shares for $4,998,934.01 on 2026-04-27, with transaction prices ranging from $105.61 to $112.13 and a blended average price of $109.03. The shares disposed represent his entire common-stock position post-transaction (0 shares remaining), though a FLAG notes this filing involves a derivative-conversion transaction, meaning his actual position may extend to Table II derivative securities not yet populated in the database. CoreWeave's stock is currently trading at $114.19, roughly 5% above the blended sale price, yet the company faces significant headwinds: it generated $-110,124,000.00 in net income over its most recent full fiscal year and is unprofitable despite strong annual revenue growth of +167.9% to $1,364,676,000.00. The timing of this large equity disposition by a senior executive warrants investor attention given the company's profitability challenges, though the multi-tranche structure and derivative conversion context prevent clear characterization of the underlying motivation.

Chief Development Officer McBee Brannin sells 287,500 CRWV shares across 24 transactions for $33,330,983.03 ($33.3M) on 2026-04-20.

McBee Brannin executed 24 separate sales totaling 287,500 shares for $33,330,983.03 at an average blended price of $115.93. The large aggregate dollar volume and the scale of share disposition merit close attention, particularly given CoreWeave's operational profile: the company generated $1,364,676,000.00 in quarterly revenue with annual growth of +167.9%, yet reported a net loss of $-110,124,000.00 most recently and negative full-year net income. The current stock price of $122.54 stands 30.2% above the sale prices executed on 2026-04-20 (blended average $115.93), meaning the insider sold ahead of the stock's subsequent appreciation. The FLAG indicates this involves a derivative-conversion transaction; the insider's total residual position extends beyond Table I and is not fully captured by the zero post-transaction share count in this filing alone.